Aine Miller is SVP, DEV & HEAD OF IRE OFFICE of Theravance Biopharma, Inc.. Currently has a direct ownership of 160,632 shares of TBPH, which is worth approximately $1.6 Million. The most recent transaction as insider was on Aug 20, 2024, when has been sold 5,201 shares (Ordinary Shares) at a price of $8.22 per share, resulting in proceeds of $42,752. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 161K
0% 3M change
n/a 12M change
Total Value Held $1.6 Million

Aine Miller Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 20 2024
SELL
Payment of exercise price or tax liability
$42,752 $8.22 p/Share
5,201 Reduced 3.14%
160,632 Ordinary Shares
May 20 2024
SELL
Payment of exercise price or tax liability
$47,329 $9.1 p/Share
5,201 Reduced 3.04%
165,833 Ordinary Shares
Apr 02 2024
BUY
Grant, award, or other acquisition
-
37,500 Added 17.98%
171,034 Ordinary Shares
Feb 20 2024
SELL
Payment of exercise price or tax liability
$105,095 $8.92 p/Share
11,782 Reduced 8.11%
133,534 Ordinary Shares
AM

Aine Miller

SVP, DEV & HEAD OF IRE OFFICE
South San Francisco, CA

Track Institutional and Insider Activities on TBPH

Follow Theravance Biopharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TBPH shares.

Notify only if

Insider Trading

Get notified when an Theravance Biopharma, Inc. insider buys or sells TBPH shares.

Notify only if

News

Receive news related to Theravance Biopharma, Inc.

Track Activities on TBPH